NCT05049733 - The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

Cannabis

Interventions

DRUG

CBD 1mg/Kg

Participants will ingest soft gel tablets containing CBD 1mg/Kg

DRUG

CBD 2mg/Kg

Participants will ingest soft gel tablets containing CBD 2mg/Kg

DRUG

CBD 4mg/Kg

Participants will ingest soft gel tablets containing CBD 4mg/Kg

DRUG

Placebo CBD

Participants will ingest soft gel tablets containing placebo for CBD

Trial Locations (1)

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore